| Oct 1, 2025 | Step Pharma | $44.0M Series C | 🧪 Ward Capoen | HealthCap, Pontifax Venture Capital, RA Capital, Ysios Capital, Bpifrance, Hadean Ventures, Inserm Transfert Initiative, Kurma Partners, Sunstone Life Science Ventures |
| Apr 24, 2024 | Flindr Therapeutics | $21.4M Series A | Christina Takke | BOM, Curie Capital, Tine Bekaert, Johnson & Johnson Innovation, Chris De Jonghe, Cedric Van Nevel, Swanbridge Capital |
| Jan 23, 2024 | Protealis | $23.9M Series B | — | Agri Investment Fund, Estari, Gemma Frisius Fund, Globachem Group, HFT Holding, ILVO, Innovation Industries, Korys, PMV, Thia Ventures |
| Sep 1, 2023 | Corteria Pharmaceuticals | $70.0M Series A | Rafaèle Tordjman, Erez Chimovits | Caixa Capital, Faber, Kurma Partners, Roche Venture Fund, Sanofi Ventures, Fountain Healthcare Partners, Invivo Capital, Omnes Capital |
| May 15, 2023 | dualyx | $43.5M Series A | Aneta Sottil, Juliette Audet, Ena Prosser | Benhamou Global Ventures, GFF, High-Tech Grunderfonds, PMV, VIB |
| Oct 1, 2022 | Sibylla Biotech | $23.0M Series A | 🧪 Ward Capoen | Marianne Bjørdal, 3B Future Health Ventures (Helsinn Investment Fund), Claris Ventures, Seroba Life Sciences, Marianne Bjordal, CDP Venture Capital, Ciro Spedaliere, Davide Turco, Roberto Della Marina, VI Partners |
| Aug 25, 2022 | AstriVax | $29.9M Seed | Caroline Goddeeris, Shelley Margetson | Ackermans & van Haaren, BNP Paribas Fortis Private Equity, Flanders Future Tech Fund, KU Leuven, Merieux Equity Partners, Thuja Capital |
| Mar 1, 2022 | Precirix | $88.0M Series B | Forbion, INKEF Capital, Sabine Dandiguian | Aglaia BioMedical Ventures, Keno Gutierrez, Novartis Venture Fund, Pfizer Venture Investments, Pontifax Venture Capital, BioMedPartners, Gimv, HealthCap, Novo Holdings |
| Dec 21, 2021 | Aphea.Bio | $20.3M Series B | Hendrik Van | Agri Investment Fund, Gemma Frisius Fund, PMV, Qbic II, VIB, VIVES Louvain Technology Fund |
| Jul 9, 2021 | Muna Therapeutics | $73.0M Series A | Droia Ventures, LSP, Morten Graugaard Døssing, Sofinnova Partners | LS Polaris Innovation Fund, Sanofi Ventures, VIB |
| May 24, 2021 | ExeVir Bio | $50.0M Series A | Philippe Monteyne | Belgian family offices, Noshaq, Sambrinvest, Stef HEYLEN, MD, Caroline THIELEN, Erica Whittaker, Katja Rosenkranz, Jerome Van Biervliet, Joël Henneghien |
| Feb 1, 2021 | Oxular | $37.0M Series B | Forbion | NeoMed Management |
| Jul 28, 2020 | ExeVir Bio | $27.0M Other Equity | Philippe Monteyne | SFPI-FPIM, Erica Whittaker, Katja Rosenkranz, Jerome Van Biervliet |
| Jan 22, 2020 | RootWave | $7.2M Series A | Richard O’Gorman, Willem Broekaert | Pieter Vis, The Yield Lab Europe |
| Nov 1, 2018 | Precirix | $42.0M Series A | Karl Nagler, Christina Takke | Abingworth, Forbion, HealthCap, Novartis Venture Fund, Pfizer Venture Investments, Pontifax Venture Capital, BioMedPartners, Morten Graugaard Døssing |
| Feb 9, 2018 | Syndesi Therapeutics | $20.8M Series A | Fountain Healthcare Partners, Novo Seeds | Johnson & Johnson Innovation, SRIW, VIVES Louvain Technology Fund |
| Jun 26, 2017 | Aphea.Bio | $8.6M Series A | Willem Broekaert | Agri Investment Fund, Gemma Frisius Fund, Group De Ceuster, PMV, Qbic II, Philippe Durieux |
| Jul 19, 2016 | Oxular | $20.3M Series A | — | Hovione Scientia, Imperial Innovations, NeoMed Management, Christina Takke |
